(NP (NP A/DT mutation/NN) (PP of/IN (NP the/DT glucocorticoid/NN receptor/NN)) (PP in/IN (NP primary/JJ cortisol/NN resistance/NN)) ./.)
(S (NP-SBJ-24 (NP The/DT precise/JJ molecular/JJ abnormalities/NNS) (SBAR (WHNP-104 that/WDT) (S (NP-SBJ *T*-104/-NONE-) (VP cause/VBP (NP primary/JJ cortisol/NN resistance/NN))))) (VP have/VBP not/RB (VP been/VBN (VP (ADVP completely/RB) described/VBN (NP *-24/-NONE-)))) ./.)
(S (PP In/IN (NP (NP a/DT subject/NN) (PP with/IN (NP primary/JJ cortisol/NN resistance/NN)))) (NP-SBJ we/PRP) (VP have/VBP (VP observed/VBN (NP (NP (NP glucocorticoid/NN receptors/NNS) (PRN -LRB-/-LRB- (NP hGR/NN) -RRB-/-RRB-)) (PP with/IN (NP (NP a/DT decreased/VBN affinity/NN) (PP for/IN (NP dexamethasone/NN))))))) ./.)
(S (NP-SBJ We/PRP) (VP hypothesize/VBP (SBAR that/IN (S (NP-SBJ (NP a/DT mutation/NN) (PP of/IN (NP the/DT hGR/NN glucocorticoid-binding/JJ domain/NN))) (VP is/VBZ (NP-PRD (NP the/DT cause/NN) (PP of/IN (NP cortisol/NN resistance/NN))))))) ./.)
(S-COOD (S (NP-SBJ-25 (NP Total/JJ RNA/NN) (VP isolated/VBN (NP */-NONE-) (PP from/IN (NP (NP the/DT index/NN subject/NN 's/POS) mononuclear/JJ leukocytes/NNS)))) (VP was/VBD (VP used/VBN (NP-26 *-25/-NONE-) (S (NP-SBJ *-26/-NONE-) (VP to/TO (VP produce/VB (NP first/JJ strand/NN hGR/NN cDNAs/NNS))))))) ,/, and/CC (S (NP-SBJ-27 the/DT entire/JJ hGR/NN cDNA/NN) (VP was/VBD (VP-COOD (VP amplified/VBN (NP *-27/-NONE-) (PP in/IN (NP segments/NNS))) and/CC (VP sequenced/VBN (NP *-27/-NONE-))))) ./.)
(S (PP At/IN (NP nucleotide/NN 2,317/CD)) (NP-SBJ we/PRP) (VP identified/VBD (NP (NP a/DT homozygous/JJ A/NN) (PP for/IN (NP (NP G/NN point/NN mutation/NN) (SBAR (WHNP-29 that/WDT) (S (NP-SBJ *T*-29/-NONE-) (VP predicts/VBZ (NP (NP (NP an/DT isoleucine/NN) (PRN -LRB-/-LRB- (NP ATT/NN) -RRB-/-RRB-)) (PP for/IN (NP (NP valine/NN -LRB-/-LRB- GTT/NN -RRB-/-RRB- substitution/NN) (PP at/IN (NP amino/NN acid/NN 729/CD)))))))))))) ./.)
(S (SBAR-TMP (WHADVP-30 When/WRB) (S (NP-SBJ-COOD-31 (NP the/DT wild-type/JJ hGR/NN) and/CC (NP hGR-Ile/NN 729/CD)) (VP were/VBD (VP (VP-COOD (VP expressed/VBN (NP *-31/-NONE-) (PP in/IN (NP COS-1/NN cells/NNS))) and/CC (VP assayed/VBN (NP *-31/-NONE-) (PP for/IN (NP -LCB-3H-RCB--Dexamethasone/NN binding/NN)))) (ADVP *T*-30/-NONE-))))) ,/, (NP-SBJ the/DT dissociation/NN constants/NNS) (VP were/VBD (NP-PRD (NP (QP-COOD (QP 0.799/CD +\/-/CC 0.068/CD) and/CC (QP 1.54/CD +\/-/CC 0.06/CD)) nM/NN) (PRN -LRB-/-LRB- (NP-COOD (NP mean/NN) +\/-/CC (NP SEM/NN)) -RRB-/-RRB-) (PRN -LRB-/-LRB- (S (NP-SBJ P/NN) (NP-PRD (QP &lt;/JJR 0.01/CD))) -RRB-/-RRB-) ,/, (ADVP respectively/RB))) ./.)
(S (SBAR-TMP (WHADVP-34 When/WRB) (S (NP-SBJ-COOD-35 (NP the/DT wild-type/JJ hGR/NN) and/CC (NP hGR-Ile/NN 729/CD)) (VP were/VBD (VP expressed/VBN (NP *-35/-NONE-) (PP in/IN (NP (NP CV-1/NN cells/NNS) (SBAR (WHNP-36 that/WDT) (S (NP-SBJ-37 *T*-36/-NONE-) (VP were/VBD (VP cotransfected/VBN (NP *-37/-NONE-) (PP with/IN (NP (NP the/DT mouse/NN mammary/JJ tumor/NN virus/NN long/JJ terminal/JJ repeat/NN) (VP fused/VBN (NP */-NONE-) (PP to/TO (NP the/DT (NP (NP chloramphenicol/NN acetyl/NN transferase/NN) (PRN -LRB-/-LRB- (NP CAT/NN) -RRB-/-RRB-)) gene/NN))))))))))) (ADVP *T*-34/-NONE-))))) ,/, (NP-SBJ the/DT hGR-Ile/NN 729/CD) (VP conferred/VBD (NP (NP a/DT fourfold/JJ decrease/NN) (PP in/IN (NP apparent/JJ potency/NN))) (PP on/IN (NP (NP dexamethasone/NN stimulation/NN) (PP of/IN (NP CAT/NN activity/NN))))) ./.)
(S (NP-SBJ (NP The/DT isoleucine/NN) (PP for/IN (NP (NP valine/NN substitution/NN) (PP at/IN (NP amino/NN acid/NN 729/CD))))) (VP-COOD (VP impairs/VBZ (NP (NP the/DT function/NN) (PP of/IN (NP the/DT hGR/NN)))) and/CC (VP is/VBZ (NP-PRD (NP the/DT likely/JJ cause/NN) (PP of/IN (NP (NP primary/JJ cortisol/NN resistance/NN) (PP in/IN (NP this/DT subject/NN))))))) ./.)
